Close
Smartlab Europe
Inizio Ignite

Press Releases

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being released today so that vaccinations may begin early in the New Year. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided...

FedEx to Ship First Wave of Moderna COVID-19 Vaccines Across the United States

FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, announced that operations are in motion to transport Moderna’s COVID-19 vaccines for McKesson Corp. throughout the United States. Following the Food and Drug Administration’s...

Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

Vir Biotechnology, Inc. announced that the first patient has been dosed in a new sub-trial of the National Institutes of Health’s (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Program Phase 3 clinical trial. This trial is designed to...

Pelican BioThermal Announces Korean Air Cargo Partnership

Pelican BioThermal, the global name in temperature controlled packaging, announces its new partnership with Korean Air Cargo, the latest in the company’s expanding network of worldwide alliances. The significant new partnership will see the Asia airline utilize Pelican BioThermal’s Cr?do™...

Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the U.S. FDA has authorized the emergency use of mRNA-1273, Moderna’s vaccine against COVID-19 in individuals 18 years of age or older. The Moderna COVID-19...

Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing

Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif. The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used...

Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity

Aurinia Pharmaceuticals Inc. announced they have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp, Switzerland. The dedicated facility (also referred...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »